Suppr超能文献

p21WAF1/CIP1和MDM2在非霍奇金淋巴瘤中的表达及其与p53状态的关系:一种与错义p53突变相关的p53+、MDM2-、p21免疫表型。

p21WAF1/CIP1 and MDM2 expression in non-Hodgkin's lymphoma and their relationship to p53 status: a p53+, MDM2-, p21-immunophenotype associated with missense p53 mutations.

作者信息

Villuendas R, Pezzella F, Gatter K, Algara P, Sánchez-Beato M, Martínez P, Martínez J C, Muñoz K, García P, Sánchez L, Kocialkowsky S, Campo E, Orradre J L, Piris M A

机构信息

Department of Genetics, Virgen de la Salud Hospital, Toledo, Spain.

出版信息

J Pathol. 1997 Jan;181(1):51-61. doi: 10.1002/(SICI)1096-9896(199701)181:1<51::AID-PATH689>3.0.CO;2-N.

Abstract

p53 is a tumour suppressor gene which is often found to be inactivated in most types of human cancer. p53 is a transcription factor, the inactivation of which may lead to significant variations in the levels of p53 downstream proteins, such as p21WAF1/CIP1 and MDM2. In view of the significance of p21WAF1/CIP1 and MDM2 as wild-type (wt) p53 targets, this study was undertaken to monitor the varying expression of these proteins in non-Hodgkin's lymphomas (NHLs) in relation to p53 gene status. A total of 57 cases of different histological types of NHL were included in this study. Proteins p53, p21WAF1/CIP1, and MDM2 were analysed by immunohistochemical techniques, taking the levels expressed in reactive lymphoid tissues as reference points. p53 gene point mutations (exons 5-8) were looked for using the PCR-SSCP technique and direct sequencing. Fifteen of the 57 cases studied showed 16 mutations at the p53 gene: 12 missense, one nonsense, two silent mutations, and one frameshift deletion. Most missense mutations were associated with high levels of p53 protein, while the nonsense mutations and frameshift deletion did not induce detectable levels of p53. All cases with mutation at the p53 gene (15) showed null or low levels of p21WAF1/CIP1 and MDM2 proteins, suggesting that null or missense mutations at this gene give rise to a protein that is unable to transactivate the p21WAF1/CIP1 and MDM2 genes. The association between missense p53 mutation and dissociate immunophenotype (p53+, MDM2-, p21-) was statistically significant (Fisher's exact test, P = 0.0024). This anomalous p53+, MDM2-, p21- phenotype was also found in a small group of five cases with wt p53; this could indicate that in these cases p53 transactivation capacity has been abrogated by a mechanism other than p53 mutation. Most cases with the wt p53 gene show simultaneous immunohistochemical expression of all three proteins and often display higher levels than those found in reactive lymphoid tissue. There is a tendency for EBV-positive cases to harbour high levels of p53+ and p21+, suggesting that EBV could be involved in the nuclear accumulation of p53 and p21WAF1/CIP1 in NHL.

摘要

p53是一种肿瘤抑制基因,在大多数类型的人类癌症中常常被发现处于失活状态。p53是一种转录因子,其失活可能导致p53下游蛋白(如p21WAF1/CIP1和MDM2)水平的显著变化。鉴于p21WAF1/CIP1和MDM2作为野生型(wt)p53靶点的重要性,本研究旨在监测这些蛋白在非霍奇金淋巴瘤(NHL)中的表达变化与p53基因状态的关系。本研究共纳入57例不同组织学类型的NHL。采用免疫组化技术分析p53、p21WAF1/CIP1和MDM2蛋白,以反应性淋巴组织中表达的水平作为参考点。使用PCR-SSCP技术和直接测序寻找p53基因点突变(外显子5-8)。在研究的57例病例中,有15例在p53基因出现16个突变:12个错义突变、1个无义突变、2个沉默突变和1个移码缺失。大多数错义突变与高水平的p53蛋白相关,而无义突变和移码缺失未诱导可检测水平的p53。所有p53基因发生突变的病例(15例)均显示p21WAF1/CIP1和MDM2蛋白水平缺失或较低,这表明该基因的缺失或错义突变产生了一种无法反式激活p21WAF1/CIP1和MDM2基因的蛋白。错义p53突变与解离免疫表型(p53+、MDM2- 、p21-)之间的关联具有统计学意义(Fisher精确检验,P = 0.0024)。在一小群5例wt p53的病例中也发现了这种异常的p53+、MDM2- 、p21- 表型;这可能表明在这些病例中,p53的反式激活能力已被p53突变以外的机制废除。大多数具有wt p53基因的病例显示这三种蛋白同时呈免疫组化表达,且表达水平通常高于反应性淋巴组织中的水平。EBV阳性病例有携带高水平p53+和p21+的趋势,这表明EBV可能参与了NHL中p53和p21WAF1/CIP1的核内积累。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验